NEW YORK – The US Centers for Disease Control and Prevention will begin implementing surveillance for the novel coronavirus 2019-nCoV, also known as SARS-CoV-2, at select public health labs. The testing will be piggybacked onto a pre-existing national influenza surveillance system.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.